From 523ad8978303339a7a5f6903b82cac505230ccff Mon Sep 17 00:00:00 2001 From: Paul-Christian Volkmer Date: Fri, 11 Jul 2025 23:15:18 +0200 Subject: [PATCH] Initial commit --- .github/workflows/deploy.yml | 26 + .gitignore | 5 + Cargo.toml | 52 + Dockerfile | 23 + LICENSE.txt | 661 +++++++ README.md | 134 ++ dev-compose.yml | 18 + src/auth.rs | 68 + src/cli.rs | 37 + src/main.rs | 132 ++ src/routes.rs | 107 + src/sender.rs | 79 + test-files/mv64e-mtb-fake-patient.json | 2509 ++++++++++++++++++++++++ 13 files changed, 3851 insertions(+) create mode 100644 .github/workflows/deploy.yml create mode 100644 .gitignore create mode 100644 Cargo.toml create mode 100644 Dockerfile create mode 100644 LICENSE.txt create mode 100644 README.md create mode 100644 dev-compose.yml create mode 100644 src/auth.rs create mode 100644 src/cli.rs create mode 100644 src/main.rs create mode 100644 src/routes.rs create mode 100644 src/sender.rs create mode 100644 test-files/mv64e-mtb-fake-patient.json diff --git a/.github/workflows/deploy.yml b/.github/workflows/deploy.yml new file mode 100644 index 0000000..2e88ea2 --- /dev/null +++ b/.github/workflows/deploy.yml @@ -0,0 +1,26 @@ +name: "Run build and deploy" + +on: + push: + branches: [ 'master' ] + +jobs: + docker: + runs-on: ubuntu-latest + steps: + - uses: actions/checkout@v4 + + - name: Set up Docker Buildx + uses: docker/setup-buildx-action@v3 + + - name: Login to Docker Hub + uses: docker/login-action@v3 + with: + registry: ghcr.io + username: ${{ github.actor }} + password: ${{ secrets.GITHUB_TOKEN }} + + - name: Execute image build and push + run: | + docker build -t ghcr.io/pcvolkmer/dnpm-kafka-rest-proxy . + docker push ghcr.io/pcvolkmer/dnpm-kafka-rest-proxy \ No newline at end of file diff --git a/.gitignore b/.gitignore new file mode 100644 index 0000000..4e57c52 --- /dev/null +++ b/.gitignore @@ -0,0 +1,5 @@ +/.idea +/target + +*.iml +Cargo.lock diff --git a/Cargo.toml b/Cargo.toml new file mode 100644 index 0000000..2a5fd9b --- /dev/null +++ b/Cargo.toml @@ -0,0 +1,52 @@ +[package] +name = "dnpm-kafka-rest-proxy" +version = "0.1.0" +edition = "2024" +authors = ["Paul-Christian Volkmer "] +license = "AGPL-3.0" +description = "DNPM MTB REST Proxy für Kafka" + +# Dependencies + +[dependencies] +clap = { version = "4.5", features = ["derive", "env"] } +log = "0.4" +axum = { version = "0.8", features = ["tracing"] } +tracing = "0.1" +tracing-subscriber = "0.3" +tokio = { version = "1.46", features = ["rt-multi-thread"] } +tower-http = { version = "0.6", features = ["trace"] } +serde = { version = "1.0", features = ["derive"] } +serde_json = "1.0" +uuid = { version = "1.17", features = ["v4"] } +base64 = "0.22" +bcrypt = "0.17" +rdkafka = { version = "0.38.0", features = ["cmake-build", "libz-static"] } +async-trait = "0.1" +# DTOs +mv64e-mtb-dto = { git = "https://github.com/dnpm-dip/mv64e-mtb-dto-rs", branch = "master" } + +[dev-dependencies] +tower = "0.5" +http-body-util = "0.1" +mockall = "0.13" + +# Lints + +[lints.clippy] +unwrap_used = "deny" +expect_used = "deny" +panic = "deny" +pedantic = { level = "warn", priority = -1 } + +[lints.rust] +unused_must_use = "deny" + +# Profiles + +[profile.release] +opt-level = "s" +codegen-units = 1 +lto = "thin" +strip = true +panic = "abort" diff --git a/Dockerfile b/Dockerfile new file mode 100644 index 0000000..9d70343 --- /dev/null +++ b/Dockerfile @@ -0,0 +1,23 @@ +FROM rust:alpine AS back-stage + +RUN apk update +RUN apk add cmake make musl-dev g++ + +WORKDIR /build +COPY Cargo.toml ./ +COPY src ./src +COPY test-files ./test-files +# Run tests before release build +RUN cargo test --release +RUN cargo build --release + +# Build image from scratch +FROM scratch +LABEL org.opencontainers.image.source="https://github.com/pcvolkmer/dnpm-kafka-rest-proxy" +LABEL org.opencontainers.image.licenses="AGPL-3.0-or-later" +LABEL org.opencontainers.image.description="DNPM MTB REST Proxy für Kafka" + +COPY --from=back-stage /build/target/release/dnpm-kafka-rest-proxy . +USER 65532 +EXPOSE 3000 +CMD ["./bwhc-kafka-rest-proxy"] \ No newline at end of file diff --git a/LICENSE.txt b/LICENSE.txt new file mode 100644 index 0000000..0ad25db --- /dev/null +++ b/LICENSE.txt @@ -0,0 +1,661 @@ + GNU AFFERO GENERAL PUBLIC LICENSE + Version 3, 19 November 2007 + + Copyright (C) 2007 Free Software Foundation, Inc. + Everyone is permitted to copy and distribute verbatim copies + of this license document, but changing it is not allowed. + + Preamble + + The GNU Affero General Public License is a free, copyleft license for +software and other kinds of works, specifically designed to ensure +cooperation with the community in the case of network server software. + + The licenses for most software and other practical works are designed +to take away your freedom to share and change the works. By contrast, +our General Public Licenses are intended to guarantee your freedom to +share and change all versions of a program--to make sure it remains free +software for all its users. + + When we speak of free software, we are referring to freedom, not +price. Our General Public Licenses are designed to make sure that you +have the freedom to distribute copies of free software (and charge for +them if you wish), that you receive source code or can get it if you +want it, that you can change the software or use pieces of it in new +free programs, and that you know you can do these things. + + Developers that use our General Public Licenses protect your rights +with two steps: (1) assert copyright on the software, and (2) offer +you this License which gives you legal permission to copy, distribute +and/or modify the software. + + A secondary benefit of defending all users' freedom is that +improvements made in alternate versions of the program, if they +receive widespread use, become available for other developers to +incorporate. Many developers of free software are heartened and +encouraged by the resulting cooperation. However, in the case of +software used on network servers, this result may fail to come about. +The GNU General Public License permits making a modified version and +letting the public access it on a server without ever releasing its +source code to the public. + + The GNU Affero General Public License is designed specifically to +ensure that, in such cases, the modified source code becomes available +to the community. It requires the operator of a network server to +provide the source code of the modified version running there to the +users of that server. Therefore, public use of a modified version, on +a publicly accessible server, gives the public access to the source +code of the modified version. + + An older license, called the Affero General Public License and +published by Affero, was designed to accomplish similar goals. This is +a different license, not a version of the Affero GPL, but Affero has +released a new version of the Affero GPL which permits relicensing under +this license. + + The precise terms and conditions for copying, distribution and +modification follow. + + TERMS AND CONDITIONS + + 0. Definitions. + + "This License" refers to version 3 of the GNU Affero General Public License. + + "Copyright" also means copyright-like laws that apply to other kinds of +works, such as semiconductor masks. + + "The Program" refers to any copyrightable work licensed under this +License. Each licensee is addressed as "you". "Licensees" and +"recipients" may be individuals or organizations. + + To "modify" a work means to copy from or adapt all or part of the work +in a fashion requiring copyright permission, other than the making of an +exact copy. The resulting work is called a "modified version" of the +earlier work or a work "based on" the earlier work. + + A "covered work" means either the unmodified Program or a work based +on the Program. + + To "propagate" a work means to do anything with it that, without +permission, would make you directly or secondarily liable for +infringement under applicable copyright law, except executing it on a +computer or modifying a private copy. Propagation includes copying, +distribution (with or without modification), making available to the +public, and in some countries other activities as well. + + To "convey" a work means any kind of propagation that enables other +parties to make or receive copies. Mere interaction with a user through +a computer network, with no transfer of a copy, is not conveying. + + An interactive user interface displays "Appropriate Legal Notices" +to the extent that it includes a convenient and prominently visible +feature that (1) displays an appropriate copyright notice, and (2) +tells the user that there is no warranty for the work (except to the +extent that warranties are provided), that licensees may convey the +work under this License, and how to view a copy of this License. If +the interface presents a list of user commands or options, such as a +menu, a prominent item in the list meets this criterion. + + 1. Source Code. + + The "source code" for a work means the preferred form of the work +for making modifications to it. "Object code" means any non-source +form of a work. + + A "Standard Interface" means an interface that either is an official +standard defined by a recognized standards body, or, in the case of +interfaces specified for a particular programming language, one that +is widely used among developers working in that language. + + The "System Libraries" of an executable work include anything, other +than the work as a whole, that (a) is included in the normal form of +packaging a Major Component, but which is not part of that Major +Component, and (b) serves only to enable use of the work with that +Major Component, or to implement a Standard Interface for which an +implementation is available to the public in source code form. A +"Major Component", in this context, means a major essential component +(kernel, window system, and so on) of the specific operating system +(if any) on which the executable work runs, or a compiler used to +produce the work, or an object code interpreter used to run it. + + The "Corresponding Source" for a work in object code form means all +the source code needed to generate, install, and (for an executable +work) run the object code and to modify the work, including scripts to +control those activities. However, it does not include the work's +System Libraries, or general-purpose tools or generally available free +programs which are used unmodified in performing those activities but +which are not part of the work. For example, Corresponding Source +includes interface definition files associated with source files for +the work, and the source code for shared libraries and dynamically +linked subprograms that the work is specifically designed to require, +such as by intimate data communication or control flow between those +subprograms and other parts of the work. + + The Corresponding Source need not include anything that users +can regenerate automatically from other parts of the Corresponding +Source. + + The Corresponding Source for a work in source code form is that +same work. + + 2. Basic Permissions. + + All rights granted under this License are granted for the term of +copyright on the Program, and are irrevocable provided the stated +conditions are met. This License explicitly affirms your unlimited +permission to run the unmodified Program. The output from running a +covered work is covered by this License only if the output, given its +content, constitutes a covered work. This License acknowledges your +rights of fair use or other equivalent, as provided by copyright law. + + You may make, run and propagate covered works that you do not +convey, without conditions so long as your license otherwise remains +in force. You may convey covered works to others for the sole purpose +of having them make modifications exclusively for you, or provide you +with facilities for running those works, provided that you comply with +the terms of this License in conveying all material for which you do +not control copyright. Those thus making or running the covered works +for you must do so exclusively on your behalf, under your direction +and control, on terms that prohibit them from making any copies of +your copyrighted material outside their relationship with you. + + Conveying under any other circumstances is permitted solely under +the conditions stated below. Sublicensing is not allowed; section 10 +makes it unnecessary. + + 3. Protecting Users' Legal Rights From Anti-Circumvention Law. + + No covered work shall be deemed part of an effective technological +measure under any applicable law fulfilling obligations under article +11 of the WIPO copyright treaty adopted on 20 December 1996, or +similar laws prohibiting or restricting circumvention of such +measures. + + When you convey a covered work, you waive any legal power to forbid +circumvention of technological measures to the extent such circumvention +is effected by exercising rights under this License with respect to +the covered work, and you disclaim any intention to limit operation or +modification of the work as a means of enforcing, against the work's +users, your or third parties' legal rights to forbid circumvention of +technological measures. + + 4. Conveying Verbatim Copies. + + You may convey verbatim copies of the Program's source code as you +receive it, in any medium, provided that you conspicuously and +appropriately publish on each copy an appropriate copyright notice; +keep intact all notices stating that this License and any +non-permissive terms added in accord with section 7 apply to the code; +keep intact all notices of the absence of any warranty; and give all +recipients a copy of this License along with the Program. + + You may charge any price or no price for each copy that you convey, +and you may offer support or warranty protection for a fee. + + 5. Conveying Modified Source Versions. + + You may convey a work based on the Program, or the modifications to +produce it from the Program, in the form of source code under the +terms of section 4, provided that you also meet all of these conditions: + + a) The work must carry prominent notices stating that you modified + it, and giving a relevant date. + + b) The work must carry prominent notices stating that it is + released under this License and any conditions added under section + 7. This requirement modifies the requirement in section 4 to + "keep intact all notices". + + c) You must license the entire work, as a whole, under this + License to anyone who comes into possession of a copy. This + License will therefore apply, along with any applicable section 7 + additional terms, to the whole of the work, and all its parts, + regardless of how they are packaged. This License gives no + permission to license the work in any other way, but it does not + invalidate such permission if you have separately received it. + + d) If the work has interactive user interfaces, each must display + Appropriate Legal Notices; however, if the Program has interactive + interfaces that do not display Appropriate Legal Notices, your + work need not make them do so. + + A compilation of a covered work with other separate and independent +works, which are not by their nature extensions of the covered work, +and which are not combined with it such as to form a larger program, +in or on a volume of a storage or distribution medium, is called an +"aggregate" if the compilation and its resulting copyright are not +used to limit the access or legal rights of the compilation's users +beyond what the individual works permit. Inclusion of a covered work +in an aggregate does not cause this License to apply to the other +parts of the aggregate. + + 6. Conveying Non-Source Forms. + + You may convey a covered work in object code form under the terms +of sections 4 and 5, provided that you also convey the +machine-readable Corresponding Source under the terms of this License, +in one of these ways: + + a) Convey the object code in, or embodied in, a physical product + (including a physical distribution medium), accompanied by the + Corresponding Source fixed on a durable physical medium + customarily used for software interchange. + + b) Convey the object code in, or embodied in, a physical product + (including a physical distribution medium), accompanied by a + written offer, valid for at least three years and valid for as + long as you offer spare parts or customer support for that product + model, to give anyone who possesses the object code either (1) a + copy of the Corresponding Source for all the software in the + product that is covered by this License, on a durable physical + medium customarily used for software interchange, for a price no + more than your reasonable cost of physically performing this + conveying of source, or (2) access to copy the + Corresponding Source from a network server at no charge. + + c) Convey individual copies of the object code with a copy of the + written offer to provide the Corresponding Source. This + alternative is allowed only occasionally and noncommercially, and + only if you received the object code with such an offer, in accord + with subsection 6b. + + d) Convey the object code by offering access from a designated + place (gratis or for a charge), and offer equivalent access to the + Corresponding Source in the same way through the same place at no + further charge. You need not require recipients to copy the + Corresponding Source along with the object code. If the place to + copy the object code is a network server, the Corresponding Source + may be on a different server (operated by you or a third party) + that supports equivalent copying facilities, provided you maintain + clear directions next to the object code saying where to find the + Corresponding Source. Regardless of what server hosts the + Corresponding Source, you remain obligated to ensure that it is + available for as long as needed to satisfy these requirements. + + e) Convey the object code using peer-to-peer transmission, provided + you inform other peers where the object code and Corresponding + Source of the work are being offered to the general public at no + charge under subsection 6d. + + A separable portion of the object code, whose source code is excluded +from the Corresponding Source as a System Library, need not be +included in conveying the object code work. + + A "User Product" is either (1) a "consumer product", which means any +tangible personal property which is normally used for personal, family, +or household purposes, or (2) anything designed or sold for incorporation +into a dwelling. In determining whether a product is a consumer product, +doubtful cases shall be resolved in favor of coverage. For a particular +product received by a particular user, "normally used" refers to a +typical or common use of that class of product, regardless of the status +of the particular user or of the way in which the particular user +actually uses, or expects or is expected to use, the product. A product +is a consumer product regardless of whether the product has substantial +commercial, industrial or non-consumer uses, unless such uses represent +the only significant mode of use of the product. + + "Installation Information" for a User Product means any methods, +procedures, authorization keys, or other information required to install +and execute modified versions of a covered work in that User Product from +a modified version of its Corresponding Source. The information must +suffice to ensure that the continued functioning of the modified object +code is in no case prevented or interfered with solely because +modification has been made. + + If you convey an object code work under this section in, or with, or +specifically for use in, a User Product, and the conveying occurs as +part of a transaction in which the right of possession and use of the +User Product is transferred to the recipient in perpetuity or for a +fixed term (regardless of how the transaction is characterized), the +Corresponding Source conveyed under this section must be accompanied +by the Installation Information. But this requirement does not apply +if neither you nor any third party retains the ability to install +modified object code on the User Product (for example, the work has +been installed in ROM). + + The requirement to provide Installation Information does not include a +requirement to continue to provide support service, warranty, or updates +for a work that has been modified or installed by the recipient, or for +the User Product in which it has been modified or installed. Access to a +network may be denied when the modification itself materially and +adversely affects the operation of the network or violates the rules and +protocols for communication across the network. + + Corresponding Source conveyed, and Installation Information provided, +in accord with this section must be in a format that is publicly +documented (and with an implementation available to the public in +source code form), and must require no special password or key for +unpacking, reading or copying. + + 7. Additional Terms. + + "Additional permissions" are terms that supplement the terms of this +License by making exceptions from one or more of its conditions. +Additional permissions that are applicable to the entire Program shall +be treated as though they were included in this License, to the extent +that they are valid under applicable law. If additional permissions +apply only to part of the Program, that part may be used separately +under those permissions, but the entire Program remains governed by +this License without regard to the additional permissions. + + When you convey a copy of a covered work, you may at your option +remove any additional permissions from that copy, or from any part of +it. (Additional permissions may be written to require their own +removal in certain cases when you modify the work.) You may place +additional permissions on material, added by you to a covered work, +for which you have or can give appropriate copyright permission. + + Notwithstanding any other provision of this License, for material you +add to a covered work, you may (if authorized by the copyright holders of +that material) supplement the terms of this License with terms: + + a) Disclaiming warranty or limiting liability differently from the + terms of sections 15 and 16 of this License; or + + b) Requiring preservation of specified reasonable legal notices or + author attributions in that material or in the Appropriate Legal + Notices displayed by works containing it; or + + c) Prohibiting misrepresentation of the origin of that material, or + requiring that modified versions of such material be marked in + reasonable ways as different from the original version; or + + d) Limiting the use for publicity purposes of names of licensors or + authors of the material; or + + e) Declining to grant rights under trademark law for use of some + trade names, trademarks, or service marks; or + + f) Requiring indemnification of licensors and authors of that + material by anyone who conveys the material (or modified versions of + it) with contractual assumptions of liability to the recipient, for + any liability that these contractual assumptions directly impose on + those licensors and authors. + + All other non-permissive additional terms are considered "further +restrictions" within the meaning of section 10. If the Program as you +received it, or any part of it, contains a notice stating that it is +governed by this License along with a term that is a further +restriction, you may remove that term. If a license document contains +a further restriction but permits relicensing or conveying under this +License, you may add to a covered work material governed by the terms +of that license document, provided that the further restriction does +not survive such relicensing or conveying. + + If you add terms to a covered work in accord with this section, you +must place, in the relevant source files, a statement of the +additional terms that apply to those files, or a notice indicating +where to find the applicable terms. + + Additional terms, permissive or non-permissive, may be stated in the +form of a separately written license, or stated as exceptions; +the above requirements apply either way. + + 8. Termination. + + You may not propagate or modify a covered work except as expressly +provided under this License. Any attempt otherwise to propagate or +modify it is void, and will automatically terminate your rights under +this License (including any patent licenses granted under the third +paragraph of section 11). + + However, if you cease all violation of this License, then your +license from a particular copyright holder is reinstated (a) +provisionally, unless and until the copyright holder explicitly and +finally terminates your license, and (b) permanently, if the copyright +holder fails to notify you of the violation by some reasonable means +prior to 60 days after the cessation. + + Moreover, your license from a particular copyright holder is +reinstated permanently if the copyright holder notifies you of the +violation by some reasonable means, this is the first time you have +received notice of violation of this License (for any work) from that +copyright holder, and you cure the violation prior to 30 days after +your receipt of the notice. + + Termination of your rights under this section does not terminate the +licenses of parties who have received copies or rights from you under +this License. If your rights have been terminated and not permanently +reinstated, you do not qualify to receive new licenses for the same +material under section 10. + + 9. Acceptance Not Required for Having Copies. + + You are not required to accept this License in order to receive or +run a copy of the Program. Ancillary propagation of a covered work +occurring solely as a consequence of using peer-to-peer transmission +to receive a copy likewise does not require acceptance. However, +nothing other than this License grants you permission to propagate or +modify any covered work. These actions infringe copyright if you do +not accept this License. Therefore, by modifying or propagating a +covered work, you indicate your acceptance of this License to do so. + + 10. Automatic Licensing of Downstream Recipients. + + Each time you convey a covered work, the recipient automatically +receives a license from the original licensors, to run, modify and +propagate that work, subject to this License. You are not responsible +for enforcing compliance by third parties with this License. + + An "entity transaction" is a transaction transferring control of an +organization, or substantially all assets of one, or subdividing an +organization, or merging organizations. If propagation of a covered +work results from an entity transaction, each party to that +transaction who receives a copy of the work also receives whatever +licenses to the work the party's predecessor in interest had or could +give under the previous paragraph, plus a right to possession of the +Corresponding Source of the work from the predecessor in interest, if +the predecessor has it or can get it with reasonable efforts. + + You may not impose any further restrictions on the exercise of the +rights granted or affirmed under this License. For example, you may +not impose a license fee, royalty, or other charge for exercise of +rights granted under this License, and you may not initiate litigation +(including a cross-claim or counterclaim in a lawsuit) alleging that +any patent claim is infringed by making, using, selling, offering for +sale, or importing the Program or any portion of it. + + 11. Patents. + + A "contributor" is a copyright holder who authorizes use under this +License of the Program or a work on which the Program is based. The +work thus licensed is called the contributor's "contributor version". + + A contributor's "essential patent claims" are all patent claims +owned or controlled by the contributor, whether already acquired or +hereafter acquired, that would be infringed by some manner, permitted +by this License, of making, using, or selling its contributor version, +but do not include claims that would be infringed only as a +consequence of further modification of the contributor version. For +purposes of this definition, "control" includes the right to grant +patent sublicenses in a manner consistent with the requirements of +this License. + + Each contributor grants you a non-exclusive, worldwide, royalty-free +patent license under the contributor's essential patent claims, to +make, use, sell, offer for sale, import and otherwise run, modify and +propagate the contents of its contributor version. + + In the following three paragraphs, a "patent license" is any express +agreement or commitment, however denominated, not to enforce a patent +(such as an express permission to practice a patent or covenant not to +sue for patent infringement). To "grant" such a patent license to a +party means to make such an agreement or commitment not to enforce a +patent against the party. + + If you convey a covered work, knowingly relying on a patent license, +and the Corresponding Source of the work is not available for anyone +to copy, free of charge and under the terms of this License, through a +publicly available network server or other readily accessible means, +then you must either (1) cause the Corresponding Source to be so +available, or (2) arrange to deprive yourself of the benefit of the +patent license for this particular work, or (3) arrange, in a manner +consistent with the requirements of this License, to extend the patent +license to downstream recipients. "Knowingly relying" means you have +actual knowledge that, but for the patent license, your conveying the +covered work in a country, or your recipient's use of the covered work +in a country, would infringe one or more identifiable patents in that +country that you have reason to believe are valid. + + If, pursuant to or in connection with a single transaction or +arrangement, you convey, or propagate by procuring conveyance of, a +covered work, and grant a patent license to some of the parties +receiving the covered work authorizing them to use, propagate, modify +or convey a specific copy of the covered work, then the patent license +you grant is automatically extended to all recipients of the covered +work and works based on it. + + A patent license is "discriminatory" if it does not include within +the scope of its coverage, prohibits the exercise of, or is +conditioned on the non-exercise of one or more of the rights that are +specifically granted under this License. You may not convey a covered +work if you are a party to an arrangement with a third party that is +in the business of distributing software, under which you make payment +to the third party based on the extent of your activity of conveying +the work, and under which the third party grants, to any of the +parties who would receive the covered work from you, a discriminatory +patent license (a) in connection with copies of the covered work +conveyed by you (or copies made from those copies), or (b) primarily +for and in connection with specific products or compilations that +contain the covered work, unless you entered into that arrangement, +or that patent license was granted, prior to 28 March 2007. + + Nothing in this License shall be construed as excluding or limiting +any implied license or other defenses to infringement that may +otherwise be available to you under applicable patent law. + + 12. No Surrender of Others' Freedom. + + If conditions are imposed on you (whether by court order, agreement or +otherwise) that contradict the conditions of this License, they do not +excuse you from the conditions of this License. If you cannot convey a +covered work so as to satisfy simultaneously your obligations under this +License and any other pertinent obligations, then as a consequence you may +not convey it at all. For example, if you agree to terms that obligate you +to collect a royalty for further conveying from those to whom you convey +the Program, the only way you could satisfy both those terms and this +License would be to refrain entirely from conveying the Program. + + 13. Remote Network Interaction; Use with the GNU General Public License. + + Notwithstanding any other provision of this License, if you modify the +Program, your modified version must prominently offer all users +interacting with it remotely through a computer network (if your version +supports such interaction) an opportunity to receive the Corresponding +Source of your version by providing access to the Corresponding Source +from a network server at no charge, through some standard or customary +means of facilitating copying of software. This Corresponding Source +shall include the Corresponding Source for any work covered by version 3 +of the GNU General Public License that is incorporated pursuant to the +following paragraph. + + Notwithstanding any other provision of this License, you have +permission to link or combine any covered work with a work licensed +under version 3 of the GNU General Public License into a single +combined work, and to convey the resulting work. The terms of this +License will continue to apply to the part which is the covered work, +but the work with which it is combined will remain governed by version +3 of the GNU General Public License. + + 14. Revised Versions of this License. + + The Free Software Foundation may publish revised and/or new versions of +the GNU Affero General Public License from time to time. Such new versions +will be similar in spirit to the present version, but may differ in detail to +address new problems or concerns. + + Each version is given a distinguishing version number. If the +Program specifies that a certain numbered version of the GNU Affero General +Public License "or any later version" applies to it, you have the +option of following the terms and conditions either of that numbered +version or of any later version published by the Free Software +Foundation. If the Program does not specify a version number of the +GNU Affero General Public License, you may choose any version ever published +by the Free Software Foundation. + + If the Program specifies that a proxy can decide which future +versions of the GNU Affero General Public License can be used, that proxy's +public statement of acceptance of a version permanently authorizes you +to choose that version for the Program. + + Later license versions may give you additional or different +permissions. However, no additional obligations are imposed on any +author or copyright holder as a result of your choosing to follow a +later version. + + 15. Disclaimer of Warranty. + + THERE IS NO WARRANTY FOR THE PROGRAM, TO THE EXTENT PERMITTED BY +APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING THE COPYRIGHT +HOLDERS AND/OR OTHER PARTIES PROVIDE THE PROGRAM "AS IS" WITHOUT WARRANTY +OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, +THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR +PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THE PROGRAM +IS WITH YOU. SHOULD THE PROGRAM PROVE DEFECTIVE, YOU ASSUME THE COST OF +ALL NECESSARY SERVICING, REPAIR OR CORRECTION. + + 16. Limitation of Liability. + + IN NO EVENT UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING +WILL ANY COPYRIGHT HOLDER, OR ANY OTHER PARTY WHO MODIFIES AND/OR CONVEYS +THE PROGRAM AS PERMITTED ABOVE, BE LIABLE TO YOU FOR DAMAGES, INCLUDING ANY +GENERAL, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE +USE OR INABILITY TO USE THE PROGRAM (INCLUDING BUT NOT LIMITED TO LOSS OF +DATA OR DATA BEING RENDERED INACCURATE OR LOSSES SUSTAINED BY YOU OR THIRD +PARTIES OR A FAILURE OF THE PROGRAM TO OPERATE WITH ANY OTHER PROGRAMS), +EVEN IF SUCH HOLDER OR OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF +SUCH DAMAGES. + + 17. Interpretation of Sections 15 and 16. + + If the disclaimer of warranty and limitation of liability provided +above cannot be given local legal effect according to their terms, +reviewing courts shall apply local law that most closely approximates +an absolute waiver of all civil liability in connection with the +Program, unless a warranty or assumption of liability accompanies a +copy of the Program in return for a fee. + + END OF TERMS AND CONDITIONS + + How to Apply These Terms to Your New Programs + + If you develop a new program, and you want it to be of the greatest +possible use to the public, the best way to achieve this is to make it +free software which everyone can redistribute and change under these terms. + + To do so, attach the following notices to the program. It is safest +to attach them to the start of each source file to most effectively +state the exclusion of warranty; and each file should have at least +the "copyright" line and a pointer to where the full notice is found. + + + Copyright (C) + + This program is free software: you can redistribute it and/or modify + it under the terms of the GNU Affero General Public License as published + by the Free Software Foundation, either version 3 of the License, or + (at your option) any later version. + + This program is distributed in the hope that it will be useful, + but WITHOUT ANY WARRANTY; without even the implied warranty of + MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the + GNU Affero General Public License for more details. + + You should have received a copy of the GNU Affero General Public License + along with this program. If not, see . + +Also add information on how to contact you by electronic and paper mail. + + If your software can interact with users remotely through a computer +network, you should also make sure that it provides a way for users to +get its source. For example, if your program is a web application, its +interface could display a "Source" link that leads users to an archive +of the code. There are many ways you could offer source, and different +solutions will be better for different programs; see section 13 for the +specific requirements. + + You should also get your employer (if you work as a programmer) or school, +if any, to sign a "copyright disclaimer" for the program, if necessary. +For more information on this, and how to apply and follow the GNU AGPL, see +. diff --git a/README.md b/README.md new file mode 100644 index 0000000..1f95d0b --- /dev/null +++ b/README.md @@ -0,0 +1,134 @@ +# DNPM Kafka Rest Proxy + +DNPM Datenmodell 2.1 REST Proxy für Kafka + +### Einordnung innerhalb einer DNPM-ETL-Strecke + +Diese Anwendung erlaubt das Weiterleiten von REST Anfragen mit einem Request-Body und Inhalt im DNPM-Datenmodell 2.1 +sowie `Content-Type` von `application/json` an einen Apache Kafka Cluster. + +Verwendung im Zusammenspiel mit https://github.com/pcvolkmer/etl-processor + +## Konfiguration + +Beim Start der Anwendung können Parameter angegeben werden. + +``` +Usage: dnpm-kafka-rest-proxy [OPTIONS] --token + +Options: + --bootstrap-server + Kafka Bootstrap-Server(s) [env: KAFKA_BOOTSTRAP_SERVERS=] [default: kafka:9094] + --topic + Kafka Topic [env: APP_KAFKA_TOPIC=] [default: etl-processor_input] + --token + bcrypt hashed Security Token [env: APP_SECURITY_TOKEN=] + --listen + Address and port for HTTP requests [env: APP_LISTEN=] [default: [::]:3000] +``` + +Die Anwendung lässt sich auch mit Umgebungsvariablen konfigurieren. + +* `APP_KAFKA_SERVERS`: Zu verwendende Kafka-Bootstrap-Server als kommagetrennte Liste +* `APP_KAFKA_TOPIC`: Zu verwendendes Topic zum Warten auf neue Anfragen. Standardwert: `etl-processor_input` +* `APP_SECURITY_TOKEN`: Verpflichtende Angabe es Tokens als *bcrypt*-Hash +* `APP_LISTEN`: Adresse und Port für eingehende HTTP-Requests. Standardwert: `[::]:3000` - Port `3000` auf allen + Adressen (IPv4 und IPv6) + +Die Angabe eines Tokens ist verpflichtend und kann entweder über den Parameter `--token` erfolgen, oder über die +Umgebungsvariable `APP_SECURITY_TOKEN`. + +## HTTP-Requests + +Die folgenden Endpunkte sind verfügbar: + +* **POST** `/mtbfile`: Senden eines MTB-Files +* **DELETE** `/mtbfile/:patient_id`: Löschen von Informationen zu dem Patienten + +Übermittelte MTB-Files müssen erforderliche Bestandteile beinhalten, ansonsten wird die Anfrage zurückgewiesen. + +Zum Löschen von Patienteninformationen wird intern ein MTB-File mit Consent-Status `REJECTED` erzeugt und weiter +geleitet. Hier ist kein Request-Body erforderlich. + +Bei Erfolg enthält die Antwort im HTTP-Header `x-request-id` die Anfrage-ID, die auch im ETL-Prozessor verwendet +wird. + +### Authentifizierung + +Requests müssen einen HTTP-Header `authorization` für HTTP-Basic enthalten. Hier ist es erforderlich, dass der +Benutzername `token` gewählt wird. + +Es ist hierzu erforderlich, die erforderliche Umgebungsvariable `APP_SECURITY_TOKEN` zu setzen. Dies kann z.B. mit +*htpasswd* erzeugt werden: + +``` +htpasswd -Bn token +``` + +Der hintere Teil (hinter `token:`) entspricht dem *bcrypt*-Hash des Tokens. + +### Beispiele für HTTP-Requests und resultierende Kafka-Records + +Beispiele für gültige HTTP-Requests zum Übermitteln und Löschen eines MTB-Files. + +#### Übermittlung eines MTB-Files + +Anfrage mit *curl*, hier mit beiliegendem Test-File: + +```bash +curl -u token:very-secret \ + -H "Content-Type: application/json" \ + --data @test-files/mv64e-mtb-fake-patient.json \ + http://localhost:3000/mtb/etl/patient-record +``` + +Antwort: + +``` +HTTP/1.1 202 Accepted +x-request-id: 1804d5c1-af3d-4f75-81a0-d9ca7c9739ef +content-length: ... +date: Sat, 09 Mar 2024 11:16:44 GMT +``` + +Resultierender Kafka-Record: + +* **Key**: `{"pid":"P1"}` +* **Headers**: + * `requestId`: `1804d5c1-af3d-4f75-81a0-d9ca7c9739ef` +* **Value**: Inhalt des HTTP-Request-Bodies/Test-Files + +#### Löschen von Patienten + +Anfrage auch hier mit *curl*: + +```bash +curl -u token:very-secret \ + -H "Content-Type: application/json" \ + -X DELETE \ + http://localhost:3000/mtb/etl/patient-record/P1 +``` + +Antwort: + +``` +HTTP/1.1 202 Accepted +x-request-id: 8473fa67-8b18-4e8f-aa89-874f74fcc672 +content-length: ... +date: Sat, 09 Mar 2024 11:24:35 GMT +``` + +Resultierender Kafka-Record: + +* **Key**: `{"pid":"P1"}` +* **Headers**: + * `requestId`: `8473fa67-8b18-4e8f-aa89-874f74fcc672` +* **Value**: JSON-String mit Patienten-ID `P1` und ohne weitere Angaben. + +Es werden keine weiteren patientenbezogenen Daten übermittelt. + +In optionaler Verbindung mit [Key-Based-Retention](https://github.com/CCC-MF/etl-processor#key-based-retention) wird +lediglich der letzte und aktuelle Record, hier die Information ohne Consent-Zustimmung, in Kafka vorgehalten. + +Trifft dieser Kafka-Record im [ETL-Prozessor](https://github.com/CCC-MF/etl-processor) ein, so wird dort ebenfalls eine +Löschanfrage ausgelöst, da keine Modellvorhaben Metadaten enthalten sind. diff --git a/dev-compose.yml b/dev-compose.yml new file mode 100644 index 0000000..23da826 --- /dev/null +++ b/dev-compose.yml @@ -0,0 +1,18 @@ +services: + kafka: + image: bitnami/kafka + hostname: kafka + ports: + - "9092:9092" + - "9094:9094" + environment: + ALLOW_PLAINTEXT_LISTENER: "yes" + KAFKA_CFG_NODE_ID: "0" + KAFKA_CFG_PROCESS_ROLES: "controller,broker" + KAFKA_CFG_LISTENERS: PLAINTEXT://:9092,CONTROLLER://:9093,EXTERNAL://:9094 + KAFKA_CFG_ADVERTISED_LISTENERS: PLAINTEXT://kafka:9092,EXTERNAL://localhost:9094 + KAFKA_CFG_LISTENER_SECURITY_PROTOCOL_MAP: CONTROLLER:PLAINTEXT,EXTERNAL:PLAINTEXT,PLAINTEXT:PLAINTEXT + KAFKA_CFG_INTER_BROKER_LISTENER_NAME: PLAINTEXT + KAFKA_CFG_AUTO_CREATE_TOPICS_ENABLE: "true" + KAFKA_CFG_CONTROLLER_QUORUM_VOTERS: 0@kafka:9093 + KAFKA_CFG_CONTROLLER_LISTENER_NAMES: CONTROLLER \ No newline at end of file diff --git a/src/auth.rs b/src/auth.rs new file mode 100644 index 0000000..b4af9e0 --- /dev/null +++ b/src/auth.rs @@ -0,0 +1,68 @@ +use base64::prelude::BASE64_STANDARD; +use base64::Engine; + +#[allow(clippy::module_name_repetitions)] +pub fn check_basic_auth(auth_header: &str, expected_token: &str) -> bool { + let split = auth_header.split(' ').collect::>(); + if split.len() == 2 && split.first().map(|first| first.to_lowercase()) == Some("basic".into()) { + if let Ok(auth) = BASE64_STANDARD.decode(split.last().unwrap_or(&"")) { + if let Ok(auth) = String::from_utf8(auth) { + let split = auth.split(':').collect::>(); + if split.len() == 2 && split.first() == Some(&"token") { + match split.last() { + None => {} + Some(&token) => { + if let Ok(true) = bcrypt::verify(token, expected_token) { + return true; + } + } + } + } + } + } + } + + false +} + +#[cfg(test)] +mod tests { + use crate::auth::check_basic_auth; + + // plain text value 'very-secret' + const EXPECTED_TOKEN: &str = "$2y$05$LIIFF4Rbi3iRVA4UIqxzPeTJ0NOn/cV2hDnSKFftAMzbEZRa42xSG"; + + #[test] + fn should_reject_non_basic_header_content() { + assert!(!check_basic_auth("token 123456789", EXPECTED_TOKEN)); + } + + #[test] + fn should_reject_invalid_basic_auth() { + assert!(!check_basic_auth("Basic 123456789", EXPECTED_TOKEN)); + } + + #[test] + fn should_reject_basic_auth_without_token_username() { + assert!(!check_basic_auth( + "Basic dXNlcjoxMjM0NTY3ODk=", + EXPECTED_TOKEN + )); + } + + #[test] + fn should_reject_basic_auth_without_wrong_token() { + assert!(!check_basic_auth( + "Basic dG9rZW46MTIzNDU2Nzg5", + EXPECTED_TOKEN + )); + } + + #[test] + fn should_accept_basic_auth_without_correct_token() { + assert!(check_basic_auth( + "Basic dG9rZW46dmVyeS1zZWNyZXQ=", + EXPECTED_TOKEN + )); + } +} diff --git a/src/cli.rs b/src/cli.rs new file mode 100644 index 0000000..b02806e --- /dev/null +++ b/src/cli.rs @@ -0,0 +1,37 @@ +use clap::Parser; + +#[derive(Parser)] +#[command(author, version, about)] +#[command(arg_required_else_help(true))] +pub struct Cli { + #[arg( + long, + alias = "kafka-servers", + env = "APP_KAFKA_SERVERS", + default_value = "kafka:9094", + help = "Kafka Bootstrap Server" + )] + pub bootstrap_server: String, + #[arg( + long, + alias = "kafka-topic", + env = "APP_KAFKA_TOPIC", + default_value = "etl-processor_input", + help = "Kafka Topic" + )] + pub topic: String, + #[arg( + long, + alias = "security-token", + env = "APP_SECURITY_TOKEN", + help = "bcrypt hashed Security Token" + )] + pub token: String, + #[arg( + long, + env = "APP_LISTEN", + default_value = "[::]:3000", + help = "Address and port for HTTP requests" + )] + pub listen: String, +} diff --git a/src/main.rs b/src/main.rs new file mode 100644 index 0000000..1698a52 --- /dev/null +++ b/src/main.rs @@ -0,0 +1,132 @@ +use axum::body::Body; +use axum::http::header::{AUTHORIZATION, CONTENT_TYPE}; +use axum::http::{HeaderValue, Request, StatusCode}; +use axum::middleware::{from_fn, Next}; +use axum::response::{IntoResponse, Response}; +use clap::Parser; +use serde::{Deserialize, Serialize}; +use std::sync::{Arc, LazyLock}; +#[cfg(debug_assertions)] +use tower_http::trace::TraceLayer; + +use crate::cli::Cli; +use crate::routes::routes; +use crate::sender::DefaultMtbFileSender; +use crate::AppResponse::{Accepted, Unauthorized, UnsupportedContentType}; + +mod auth; +mod cli; +mod routes; +mod sender; + +#[derive(Serialize, Deserialize)] +struct RecordKey { + #[serde(rename = "pid")] + patient_id: String, +} + +enum AppResponse<'a> { + Accepted(&'a str), + Unauthorized, + InternalServerError, + UnsupportedContentType, +} + +#[allow(clippy::expect_used)] +impl IntoResponse for AppResponse<'_> { + fn into_response(self) -> Response { + match self { + UnsupportedContentType => ( + StatusCode::UNSUPPORTED_MEDIA_TYPE, + "This application accepts DNPM data model version 2.1 with content type 'application/json'" + ).into_response(), + _ => match self { + Accepted(request_id) => Response::builder() + .status(StatusCode::ACCEPTED) + .header("X-Request-Id", request_id), + Unauthorized => Response::builder().status(StatusCode::UNAUTHORIZED), + _ => Response::builder().status(StatusCode::INTERNAL_SERVER_ERROR), + } + .body(Body::empty()).expect("response built"), + } + } +} + +static CONFIG: LazyLock = LazyLock::new(Cli::parse); + +#[tokio::main] +async fn main() -> Result<(), ()> { + #[cfg(debug_assertions)] + { + tracing_subscriber::fmt() + .with_max_level(tracing::Level::DEBUG) + .init(); + } + + let sender = Arc::new(DefaultMtbFileSender::new( + &CONFIG.topic, + &CONFIG.bootstrap_server, + )?); + + let routes = routes(sender) + .layer(from_fn(check_content_type_header)) + .layer(from_fn(check_basic_auth)); + + #[cfg(debug_assertions)] + let routes = routes.layer(TraceLayer::new_for_http()); + + match tokio::net::TcpListener::bind(&CONFIG.listen).await { + Ok(listener) => { + log::info!("Starting application listening on '{}'", CONFIG.listen); + if let Err(err) = axum::serve(listener, routes).await { + log::error!("Error starting application: {err}"); + } + } + Err(err) => log::error!("Error listening on '{}': {}", CONFIG.listen, err), + } + + Ok(()) +} + +async fn check_content_type_header(request: Request, next: Next) -> Response { + match request + .headers() + .get(CONTENT_TYPE) + .map(HeaderValue::as_bytes) + { + Some(b"application/json" | b"application/json; charset=utf-8") => next.run(request).await, + _ => UnsupportedContentType.into_response(), + } +} + +async fn check_basic_auth(request: Request, next: Next) -> Response { + if let Some(Ok(auth_header)) = request.headers().get(AUTHORIZATION).map(|x| x.to_str()) { + if auth::check_basic_auth(auth_header, &CONFIG.token) { + return next.run(request).await; + } + } + Unauthorized.into_response() +} + +#[cfg(test)] +mod tests { + use axum::http::StatusCode; + use axum::response::IntoResponse; + use uuid::Uuid; + + use crate::AppResponse::{Accepted, InternalServerError}; + + #[test] + fn should_return_success_response() { + let response = Accepted(&Uuid::new_v4().to_string()).into_response(); + assert_eq!(response.status(), StatusCode::ACCEPTED); + assert!(response.headers().contains_key("x-request-id")); + } + + #[test] + fn should_return_error_response() { + let response = InternalServerError.into_response(); + assert_eq!(response.status(), StatusCode::INTERNAL_SERVER_ERROR); + assert!(!response.headers().contains_key("x-request-id")); + } +} diff --git a/src/routes.rs b/src/routes.rs new file mode 100644 index 0000000..0cf22d1 --- /dev/null +++ b/src/routes.rs @@ -0,0 +1,107 @@ +use crate::sender::DynMtbFileSender; +use crate::AppResponse::{Accepted, InternalServerError}; +use axum::extract::Path; +use axum::response::{IntoResponse, Response}; +use axum::routing::{delete, post}; +use axum::{Extension, Json, Router}; +use mv64e_mtb_dto::Mtb; + +pub async fn handle_delete( + Path(patient_id): Path, + Extension(sender): Extension, +) -> Response { + let delete_mtb_file = Mtb::new_with_consent_rejected(&patient_id); + match sender.send(delete_mtb_file).await { + Ok(request_id) => Accepted(&request_id).into_response(), + _ => InternalServerError.into_response(), + } +} + +pub async fn handle_post( + Extension(sender): Extension, + Json(mtb_file): Json, +) -> Response { + match sender.send(mtb_file).await { + Ok(request_id) => Accepted(&request_id).into_response(), + _ => InternalServerError.into_response(), + } +} + +pub fn routes(sender: DynMtbFileSender) -> Router { + Router::new() + .route("/mtb/etl/patient-record", post(handle_post)) + .route( + "/mtb/etl/patient-record/{patient_id}", + delete(handle_delete), + ) + .layer(Extension(sender)) +} + +#[cfg(test)] +mod tests { + use super::*; + use crate::sender::MockMtbFileSender; + use axum::body::Body; + use axum::http::header::CONTENT_TYPE; + use axum::http::{Method, Request, StatusCode}; + use std::sync::Arc; + use tower::ServiceExt; + + #[tokio::test] + #[allow(clippy::expect_used)] + async fn should_handle_post_request() { + let mut sender_mock = MockMtbFileSender::new(); + + sender_mock + .expect_send() + .withf(|mtb| mtb.patient.id.eq("fae56ea7-24a7-4556-82fb-2b5dde71bb4d")) + .return_once(move |_| Ok(String::new())); + + let router = routes(Arc::new(sender_mock) as DynMtbFileSender); + let body = Body::from(include_str!("../test-files/mv64e-mtb-fake-patient.json")); + + let response = router + .oneshot( + Request::builder() + .method(Method::POST) + .uri("/mtb/etl/patient-record") + .header(CONTENT_TYPE, "application/json") + .body(body) + .expect("request built"), + ) + .await + .unwrap(); + + assert_eq!(response.status(), StatusCode::ACCEPTED); + } + + #[tokio::test] + #[allow(clippy::expect_used)] + async fn should_handle_delete_request() { + let mut sender_mock = MockMtbFileSender::new(); + + sender_mock + .expect_send() + // Expect patient id is set in Kafka record + .withf(|mtb| mtb.patient.id.eq("fae56ea7-24a7-4556-82fb-2b5dde71bb4d")) + // Expect no Metadata => no consent in kafka record + .withf(|mtb| mtb.metadata.is_none()) + .return_once(move |_| Ok(String::new())); + + let router = routes(Arc::new(sender_mock) as DynMtbFileSender); + + let response = router + .oneshot( + Request::builder() + .method(Method::DELETE) + .uri("/mtb/etl/patient-record/fae56ea7-24a7-4556-82fb-2b5dde71bb4d") + .header(CONTENT_TYPE, "application/json") + .body(Body::empty()) + .expect("request built"), + ) + .await + .unwrap(); + + assert_eq!(response.status(), StatusCode::ACCEPTED); + } +} diff --git a/src/sender.rs b/src/sender.rs new file mode 100644 index 0000000..b6f4484 --- /dev/null +++ b/src/sender.rs @@ -0,0 +1,79 @@ +use async_trait::async_trait; +use mv64e_mtb_dto::Mtb; +use rdkafka::message::{Header, OwnedHeaders}; +use rdkafka::producer::{FutureProducer, FutureRecord}; +use rdkafka::ClientConfig; +use std::sync::Arc; +use std::time::Duration; +use uuid::Uuid; + +#[cfg(test)] +use mockall::automock; + +use crate::RecordKey; + +pub type DynMtbFileSender = Arc; + +#[cfg_attr(test, automock)] +#[async_trait] +pub trait MtbFileSender { + async fn send(&self, mtb: Mtb) -> Result; +} + +#[allow(clippy::module_name_repetitions)] +#[derive(Clone)] +pub struct DefaultMtbFileSender { + topic: String, + producer: FutureProducer, +} + +impl DefaultMtbFileSender { + pub fn new(topic: &str, bootstrap_server: &str) -> Result { + let producer = ClientConfig::new() + .set("bootstrap.servers", bootstrap_server) + .set("message.timeout.ms", "5000") + .create::() + .map_err(|_| ())?; + + Ok(Self { + topic: topic.to_string(), + producer, + }) + } +} + +#[async_trait] +impl MtbFileSender for DefaultMtbFileSender { + async fn send(&self, mtb: Mtb) -> Result { + let request_id = Uuid::new_v4(); + + let record_key = RecordKey { + patient_id: mtb.patient.id.to_string(), + }; + + let record_headers = OwnedHeaders::default().insert(Header { + key: "requestId", + value: Some(&request_id.to_string()), + }); + + let record_key = serde_json::to_string(&record_key).map_err(|_| ())?; + + match serde_json::to_string(&mtb) { + Ok(json) => { + self.producer + .send( + FutureRecord::to(&self.topic) + .key(&record_key) + .headers(record_headers) + .payload(&json), + Duration::from_secs(1), + ) + .await + .map_err(|_| ()) + .map(|_| ())?; + Ok(request_id.to_string()) + } + Err(_) => Err(()), + } + } +} diff --git a/test-files/mv64e-mtb-fake-patient.json b/test-files/mv64e-mtb-fake-patient.json new file mode 100644 index 0000000..43fc2ef --- /dev/null +++ b/test-files/mv64e-mtb-fake-patient.json @@ -0,0 +1,2509 @@ +{ + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "gender": { + "code": "female", + "display": "Weiblich", + "system": "Gender" + }, + "birthDate": "1962-10-21", + "dateOfDeath": "2009-10-21", + "healthInsurance": { + "type": { + "code": "GKV", + "display": "gesetzliche Krankenversicherung", + "system": "http://fhir.de/CodeSystem/versicherungsart-de-basis" + }, + "reference": { + "id": "1234567890", + "system": "https://www.dguv.de/arge-ik", + "display": "AOK", + "type": "HealthInsurance" + } + }, + "address": { + "municipalityCode": "12345" + }, + "age": { + "value": 47, + "unit": "Years" + }, + "vitalStatus": { + "code": "deceased", + "display": "Verstorben", + "system": "dnpm-dip/patient/vital-status" + } + }, + "episodesOfCare": [ + { + "id": "d8b68856-3ba2-4d43-9653-6924897f5eab", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "period": { + "start": "2025-01-09" + }, + "diagnoses": [ + { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "type": "MTBDiagnosis" + } + ] + } + ], + "diagnoses": [ + { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "recordedOn": "2007-10-21", + "type": { + "history": [ + { + "value": { + "code": "main", + "display": "Hauptdiagnose", + "system": "dnpm-dip/mtb/diagnosis/type" + }, + "date": "2007-10-21" + } + ] + }, + "code": { + "code": "C72.5", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "system": "http://fhir.de/CodeSystem/bfarm/icd-10-gm", + "version": "2025" + }, + "topography": { + "code": "C72.5", + "display": "Hirnnerven o.n.A.", + "system": "urn:oid:2.16.840.1.113883.6.43.1", + "version": "Zweite Revision" + }, + "grading": { + "history": [ + { + "date": "2007-10-21", + "codes": [ + { + "code": "3", + "display": "3 = schlecht differenziert", + "system": "https://www.basisdatensatz.de/feld/161/grading" + }, + { + "code": "3", + "display": "Anaplastic astrocytoma", + "system": "dnpm-dip/mtb/who-grading-cns-tumors", + "version": "2021" + } + ] + } + ] + }, + "staging": { + "history": [ + { + "date": "2007-10-21", + "method": { + "code": "clinical", + "display": "Klinisch", + "system": "dnpm-dip/mtb/tumor-staging/method" + }, + "tnmClassification": { + "tumor": { + "code": "T0", + "system": "UICC" + }, + "nodes": { + "code": "Nx", + "system": "UICC" + }, + "metastasis": { + "code": "M0", + "system": "UICC" + } + }, + "otherClassifications": [ + { + "code": "unknown", + "display": "Unbekannt", + "system": "dnpm-dip/mtb/diagnosis/kds-tumor-spread" + } + ] + } + ] + }, + "guidelineTreatmentStatus": { + "code": "impossible", + "display": "Leitlinientherapie nicht möglich", + "system": "dnpm-dip/mtb/diagnosis/guideline-treatment-status" + }, + "notes": [ + "Notes on the tumor diagnosis..." + ] + } + ], + "familyMemberHistories": [ + { + "id": "0eac775e-ea13-49d4-a390-a5e99744ac6b", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "relationship": { + "code": "FAMMEMB", + "display": "Verwandter ersten Grades", + "system": "dnpm-dip/mtb/family-meber-history/relationship-type" + } + } + ], + "guidelineTherapies": [ + { + "id": "af77fcc8-bcdc-41fb-9989-c4ad2fd9ce3c", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "therapyLine": 8, + "intent": { + "code": "X", + "display": "Keine Angabe", + "system": "dnpm-dip/therapy/intent" + }, + "category": { + "code": "A", + "display": "Adjuvant", + "system": "dnpm-dip/therapy/category" + }, + "recordedOn": "2025-07-09", + "status": { + "code": "stopped", + "display": "Abgebrochen", + "system": "dnpm-dip/therapy/status" + }, + "statusReason": { + "code": "progression", + "display": "Progression", + "system": "dnpm-dip/therapy/status-reason" + }, + "period": { + "start": "2024-03-09", + "end": "2024-08-10" + }, + "medication": [ + { + "code": "L01XX58", + "display": "Epacadostat", + "system": "http://fhir.de/CodeSystem/bfarm/atc", + "version": "2025" + } + ], + "notes": [ + "Notes on the therapy..." + ] + }, + { + "id": "f922939a-926e-4319-90e7-488ed9027d6d", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "therapyLine": 5, + "intent": { + "code": "X", + "display": "Keine Angabe", + "system": "dnpm-dip/therapy/intent" + }, + "category": { + "code": "I", + "display": "Intraopterativ", + "system": "dnpm-dip/therapy/category" + }, + "recordedOn": "2025-07-09", + "status": { + "code": "stopped", + "display": "Abgebrochen", + "system": "dnpm-dip/therapy/status" + }, + "statusReason": { + "code": "progression", + "display": "Progression", + "system": "dnpm-dip/therapy/status-reason" + }, + "period": { + "start": "2024-04-09", + "end": "2024-09-10" + }, + "medication": [ + { + "code": "L01EG01", + "display": "Temsirolimus", + "system": "http://fhir.de/CodeSystem/bfarm/atc", + "version": "2025" + } + ], + "notes": [ + "Notes on the therapy..." + ] + } + ], + "guidelineProcedures": [ + { + "id": "b6d5bd15-356d-468a-a816-5fd955fc51a2", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "therapyLine": 2, + "intent": { + "code": "X", + "display": "Keine Angabe", + "system": "dnpm-dip/therapy/intent" + }, + "code": { + "code": "radio-therapy", + "display": "Strahlen-Therapie", + "system": "dnpm-dip/mtb/procedure/type" + }, + "status": { + "code": "on-going", + "display": "Laufend", + "system": "dnpm-dip/therapy/status" + }, + "statusReason": { + "code": "regular-completion-with-substance-change", + "display": "Reguläres Ende mit Substanzwechsel", + "system": "dnpm-dip/therapy/status-reason" + }, + "recordedOn": "2025-07-09", + "period": { + "start": "2025-01-09" + }, + "notes": [ + "Notes on the therapeutic procedure..." + ] + } + ], + "performanceStatus": [ + { + "id": "279b4954-7901-4b0b-89f3-1f90b12bcc02", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "effectiveDate": "2025-07-09", + "value": { + "code": "3", + "display": "ECOG 3", + "system": "ECOG-Performance-Status" + } + } + ], + "specimens": [ + { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "diagnosis": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "type": "MTBDiagnosis" + }, + "type": { + "code": "FFPE", + "display": "FFPE", + "system": "dnpm-dip/mtb/tumor-specimen/type" + }, + "collection": { + "date": "2025-07-09", + "method": { + "code": "biopsy", + "display": "Biopsie", + "system": "dnpm-dip/mtb/tumor-specimen/collection/method" + }, + "localization": { + "code": "local-recurrence", + "display": "Lokalrezidiv", + "system": "dnpm-dip/mtb/tumor-specimen/collection/localization" + } + } + } + ], + "priorDiagnosticReports": [ + { + "id": "a7f20f97-c9ea-424d-add6-605dc2461782", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "performer": { + "id": "xyz", + "display": "Molekular-Pathologie UKx", + "type": "Institute" + }, + "issuedOn": "2025-07-09", + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "type": { + "code": "fusion-panel", + "display": "Fusionspanel", + "system": "dnpm-dip/mtb/molecular-diagnostics/type" + }, + "results": [ + "Result of diagnostics..." + ] + } + ], + "histologyReports": [ + { + "id": "d57816b6-18b5-485d-9d7f-fc31004c429e", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "issuedOn": "2025-07-09", + "results": { + "tumorMorphology": { + "id": "21f1d157-6f40-4127-9b2f-91f32fedceb0", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "value": { + "code": "9542/3", + "display": "Epitheloider maligner peripherer Nervenscheidentumor", + "system": "urn:oid:2.16.840.1.113883.6.43.1", + "version": "Zweite Revision" + }, + "note": "Notes..." + }, + "tumorCellContent": { + "id": "81a42ef1-f9fe-4dfe-a876-cf1a262ca4ce", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "method": { + "code": "histologic", + "display": "Histologisch", + "system": "dnpm-dip/mtb/tumor-cell-content/method" + }, + "value": 0.12624946426974026 + } + } + } + ], + "ihcReports": [ + { + "id": "2046a862-66e0-4402-bb93-b64ce179d014", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "issuedOn": "2025-07-09", + "results": { + "proteinExpression": [ + { + "id": "15d628bb-6e6a-435f-98dd-8bbc2f0311d1", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "protein": { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + "value": { + "code": "1+", + "display": "1+", + "system": "dnpm-dip/mtb/ihc/protein-expression/result" + }, + "tpsScore": 42, + "icScore": { + "code": "1", + "display": ">= 1%", + "system": "dnpm-dip/mtb/ihc/protein-expression/ic-score" + }, + "tcScore": { + "code": "4", + "display": ">= 25%", + "system": "dnpm-dip/mtb/ihc/protein-expression/tc-score" + } + }, + { + "id": "a7af8f99-b917-4498-8c95-f09818906de2", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "protein": { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + "value": { + "code": "1+", + "display": "1+", + "system": "dnpm-dip/mtb/ihc/protein-expression/result" + }, + "tpsScore": 90, + "icScore": { + "code": "0", + "display": "< 1%", + "system": "dnpm-dip/mtb/ihc/protein-expression/ic-score" + }, + "tcScore": { + "code": "4", + "display": ">= 25%", + "system": "dnpm-dip/mtb/ihc/protein-expression/tc-score" + } + }, + { + "id": "ea2d53e1-9a52-4fb2-87fd-b8b9acfb4017", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "protein": { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + }, + "value": { + "code": "1+", + "display": "1+", + "system": "dnpm-dip/mtb/ihc/protein-expression/result" + }, + "tpsScore": 41, + "icScore": { + "code": "0", + "display": "< 1%", + "system": "dnpm-dip/mtb/ihc/protein-expression/ic-score" + }, + "tcScore": { + "code": "2", + "display": ">= 5%", + "system": "dnpm-dip/mtb/ihc/protein-expression/tc-score" + } + }, + { + "id": "b0794bbd-6e4e-442f-bfcf-cf2558ae3069", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "protein": { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + }, + "value": { + "code": "unknown", + "display": "untersucht, kein Ergebnis", + "system": "dnpm-dip/mtb/ihc/protein-expression/result" + }, + "tpsScore": 83, + "icScore": { + "code": "1", + "display": ">= 1%", + "system": "dnpm-dip/mtb/ihc/protein-expression/ic-score" + }, + "tcScore": { + "code": "5", + "display": ">= 50%", + "system": "dnpm-dip/mtb/ihc/protein-expression/tc-score" + } + } + ], + "msiMmr": [] + } + } + ], + "msiFindings": [ + { + "id": "73df8592-b79a-4277-ab5b-0d59c4af5659", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "method": { + "code": "PCR", + "display": "PCR", + "system": "dnpm-dip/mtb/msi/method" + }, + "value": 0.800039814642262, + "interpretation": { + "code": "msi-high", + "display": "MSI high", + "system": "dnpm-dip/mtb/msi/interpretation" + } + } + ], + "ngsReports": [ + { + "id": "76003d5a-8c9e-4587-8e39-d4c785d234ea", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "issuedOn": "2025-07-09", + "type": { + "code": "genome-long-read", + "display": "Genome long-read", + "system": "dnpm-dip/ngs/type" + }, + "metadata": [ + { + "kitType": "Kit Type", + "kitManufacturer": "Manufacturer", + "sequencer": "Sequencer", + "referenceGenome": "GRCh37", + "pipeline": "https://github.com/pipeline-project" + } + ], + "results": { + "tumorCellContent": { + "id": "a76fbe2c-7e89-4abe-af89-884d03fec74e", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "method": { + "code": "bioinformatic", + "display": "Bioinformatisch", + "system": "dnpm-dip/mtb/tumor-cell-content/method" + }, + "value": 0.28954646267764894 + }, + "tmb": { + "id": "1c94b024-1f8b-448a-a3d1-969b3e0cc9df", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "value": { + "value": 378485, + "unit": "Mutations per megabase" + }, + "interpretation": { + "code": "intermediate", + "display": "Mittel", + "system": "dnpm-dip/mtb/ngs/tmb/interpretation" + } + }, + "brcaness": { + "id": "66a288cb-41c1-40c8-9c56-0c6bd351dc1d", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "value": 0.5, + "confidenceRange": { + "min": 0.4, + "max": 0.6 + } + }, + "hrdScore": { + "id": "19947989-81e0-434b-a67e-efb465e3dce8", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "value": 0.7088427690663931, + "components": { + "lst": 0.8735934125036016, + "loh": 0.6095339305551127, + "tai": 0.013080285821030713 + }, + "interpretation": { + "code": "intermediate", + "display": "Mittel", + "system": "dnpm-dip/mtb/ngs/hrd-score/interpretation" + } + }, + "simpleVariants": [ + { + "id": "6bcf7977-44d7-47b9-8681-c1d1cd05b28e", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "67340169-c748-4ebc-9ed2-220f6abf8833", + "system": "https://www.ncbi.nlm.nih.gov/snp" + }, + { + "value": "7c7246c1-48bf-4a0b-9c3b-14077a20c400", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "chromosome": "chr8", + "gene": { + "code": "HGNC:3236", + "display": "EGFR", + "system": "https://www.genenames.org/" + }, + "localization": [ + { + "code": "intergenic", + "display": "Intergenic", + "system": "dnpm-dip/variant/localization" + } + ], + "transcriptId": { + "value": "5d55b598-db89-48f2-8d56-9fb6548c8ac6", + "system": "https://www.ensembl.org" + }, + "exonId": "9", + "position": { + "start": 504 + }, + "altAllele": "T", + "refAllele": "A", + "dnaChange": "c.504A>T", + "proteinChange": "p.His4_Gln5insAla", + "readDepth": 14, + "allelicFrequency": 0.4397302456613448, + "interpretation": { + "code": "1", + "display": "Benign", + "system": "https://www.ncbi.nlm.nih.gov/clinvar" + } + }, + { + "id": "4ba9159c-6301-49cd-b479-4337e148c835", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "bb35c242-118d-4da4-b1d7-a001f2efd9a5", + "system": "https://www.ncbi.nlm.nih.gov/snp" + }, + { + "value": "5279bcbf-c42f-4f17-b84b-403edf550c2b", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "chromosome": "chrX", + "gene": { + "code": "HGNC:33", + "display": "ABCA3", + "system": "https://www.genenames.org/" + }, + "localization": [ + { + "code": "coding-region", + "display": "Coding region", + "system": "dnpm-dip/variant/localization" + } + ], + "transcriptId": { + "value": "e4cfc607-ba2e-405d-ac45-3938792429a4", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "11", + "position": { + "start": 355 + }, + "altAllele": "C", + "refAllele": "A", + "dnaChange": "c.355A>C", + "proteinChange": "p.Trp24=/Cys", + "readDepth": 23, + "allelicFrequency": 0.6802591040502892, + "interpretation": { + "code": "2", + "display": "Likely benign", + "system": "https://www.ncbi.nlm.nih.gov/clinvar" + } + }, + { + "id": "45478b38-7eec-4bc1-b8d2-031c88f4b69c", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "acd1e368-6df8-45ff-84f2-7d367a88926d", + "system": "https://www.ncbi.nlm.nih.gov/snp" + }, + { + "value": "35c8e79b-2880-410a-812f-a56e7afae15b", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "chromosome": "chr9", + "gene": { + "code": "HGNC:76", + "display": "ABL1", + "system": "https://www.genenames.org/" + }, + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "transcriptId": { + "value": "c119ba3a-84be-41ca-822d-62aaddfba0ee", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "6", + "position": { + "start": 159 + }, + "altAllele": "T", + "refAllele": "A", + "dnaChange": "c.159A>T", + "proteinChange": "p.(Gly56Ala^Ser^Cys)", + "readDepth": 18, + "allelicFrequency": 0.24954175292406522, + "interpretation": { + "code": "4", + "display": "Likely pathogenic", + "system": "https://www.ncbi.nlm.nih.gov/clinvar" + } + }, + { + "id": "b186b7bd-9d39-47b1-bc72-2c46e6565cb2", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "0081660e-8c5b-4814-9c4a-302416f03a08", + "system": "https://www.ncbi.nlm.nih.gov/snp" + }, + { + "value": "afbf946b-d4ef-481d-9bca-265761b56be3", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "chromosome": "chr19", + "gene": { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + "localization": [ + { + "code": "intergenic", + "display": "Intergenic", + "system": "dnpm-dip/variant/localization" + } + ], + "transcriptId": { + "value": "2a641aa1-4eeb-4012-b84a-727d6c30b9bc", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "11", + "position": { + "start": 282 + }, + "altAllele": "A", + "refAllele": "T", + "dnaChange": "c.282T>A", + "proteinChange": "p.(Glu125_Ala132delinsGlyLeuHisArgPheIleValLeu)", + "readDepth": 21, + "allelicFrequency": 0.681374007445711, + "interpretation": { + "code": "5", + "display": "Pathogenic", + "system": "https://www.ncbi.nlm.nih.gov/clinvar" + } + } + ], + "copyNumberVariants": [ + { + "id": "d3e004a0-d80d-455b-af06-fe1d00e2f073", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "chromosome": "chr19", + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "startRange": { + "start": 784, + "end": 826 + }, + "endRange": { + "start": 1163, + "end": 1213 + }, + "totalCopyNumber": 7, + "relativeCopyNumber": 0.5881569243593987, + "cnA": 0.8272442044751694, + "cnB": 0.07961294501228111, + "reportedAffectedGenes": [ + { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25829", + "display": "ABRAXAS1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:6973", + "display": "MDM2", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25662", + "display": "AAGAB", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:76", + "display": "ABL1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:18615", + "display": "BRAFP1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3690", + "display": "FGFR3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3689", + "display": "FGFR2", + "system": "https://www.genenames.org/" + } + ], + "reportedFocality": "partial q-arm", + "type": { + "code": "high-level-gain", + "display": "High-level-gain", + "system": "dnpm-dip/mtb/ngs-report/cnv/type" + }, + "copyNumberNeutralLoH": [ + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:6973", + "display": "MDM2", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1100", + "display": "BRCA1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3942", + "display": "MTOR", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3236", + "display": "EGFR", + "system": "https://www.genenames.org/" + } + ] + }, + { + "id": "9ca350f8-7def-4a6b-9251-d76cda6c9066", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "chromosome": "chr7", + "localization": [ + { + "code": "intronic", + "display": "Intronic", + "system": "dnpm-dip/variant/localization" + } + ], + "startRange": { + "start": 33756, + "end": 33798 + }, + "endRange": { + "start": 33971, + "end": 34021 + }, + "totalCopyNumber": 5, + "relativeCopyNumber": 0.9849081436334101, + "cnA": 0.7654754033556277, + "cnB": 0.4113320623943184, + "reportedAffectedGenes": [ + { + "code": "HGNC:33", + "display": "ABCA3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25829", + "display": "ABRAXAS1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1100", + "display": "BRCA1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:76", + "display": "ABL1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3942", + "display": "MTOR", + "system": "https://www.genenames.org/" + } + ], + "reportedFocality": "partial q-arm", + "type": { + "code": "high-level-gain", + "display": "High-level-gain", + "system": "dnpm-dip/mtb/ngs-report/cnv/type" + }, + "copyNumberNeutralLoH": [ + { + "code": "HGNC:33", + "display": "ABCA3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3942", + "display": "MTOR", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1097", + "display": "BRAF", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25662", + "display": "AAGAB", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3689", + "display": "FGFR2", + "system": "https://www.genenames.org/" + } + ] + }, + { + "id": "3f0d9d82-46ad-44e9-85a4-fc5fccf78dae", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "chromosome": "chr7", + "localization": [ + { + "code": "splicing-region", + "display": "splicing region", + "system": "dnpm-dip/variant/localization" + } + ], + "startRange": { + "start": 5174, + "end": 5216 + }, + "endRange": { + "start": 5568, + "end": 5618 + }, + "totalCopyNumber": 4, + "relativeCopyNumber": 0.7837528048147511, + "cnA": 0.8598945814656759, + "cnB": 0.45985813940248477, + "reportedAffectedGenes": [ + { + "code": "HGNC:33", + "display": "ABCA3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25662", + "display": "AAGAB", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3236", + "display": "EGFR", + "system": "https://www.genenames.org/" + } + ], + "reportedFocality": "partial q-arm", + "type": { + "code": "high-level-gain", + "display": "High-level-gain", + "system": "dnpm-dip/mtb/ngs-report/cnv/type" + }, + "copyNumberNeutralLoH": [ + { + "code": "HGNC:33", + "display": "ABCA3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:76", + "display": "ABL1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:6407", + "display": "KRAS", + "system": "https://www.genenames.org/" + } + ] + }, + { + "id": "67beb706-0870-470e-b6c1-bf28662a60f6", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "chromosome": "chr21", + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "startRange": { + "start": 46825, + "end": 46867 + }, + "endRange": { + "start": 47805, + "end": 47855 + }, + "totalCopyNumber": 4, + "relativeCopyNumber": 0.667919646926896, + "cnA": 0.6344586287700189, + "cnB": 0.5935064515068115, + "reportedAffectedGenes": [ + { + "code": "HGNC:6973", + "display": "MDM2", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3690", + "display": "FGFR3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:76", + "display": "ABL1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3236", + "display": "EGFR", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25662", + "display": "AAGAB", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1100", + "display": "BRCA1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3689", + "display": "FGFR2", + "system": "https://www.genenames.org/" + } + ], + "reportedFocality": "partial q-arm", + "type": { + "code": "high-level-gain", + "display": "High-level-gain", + "system": "dnpm-dip/mtb/ngs-report/cnv/type" + }, + "copyNumberNeutralLoH": [ + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:6407", + "display": "KRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3236", + "display": "EGFR", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + } + ] + }, + { + "id": "302808e8-25e5-44dd-bac1-1ec3bc901fca", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "chromosome": "chr15", + "localization": [ + { + "code": "splicing-region", + "display": "splicing region", + "system": "dnpm-dip/variant/localization" + } + ], + "startRange": { + "start": 29564, + "end": 29606 + }, + "endRange": { + "start": 30496, + "end": 30546 + }, + "totalCopyNumber": 6, + "relativeCopyNumber": 0.9554782410556386, + "cnA": 0.14914124694657616, + "cnB": 0.04403923699882417, + "reportedAffectedGenes": [ + { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25829", + "display": "ABRAXAS1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3690", + "display": "FGFR3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:76", + "display": "ABL1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:18615", + "display": "BRAFP1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1097", + "display": "BRAF", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25662", + "display": "AAGAB", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1100", + "display": "BRCA1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + } + ], + "reportedFocality": "partial q-arm", + "type": { + "code": "high-level-gain", + "display": "High-level-gain", + "system": "dnpm-dip/mtb/ngs-report/cnv/type" + }, + "copyNumberNeutralLoH": [ + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:6973", + "display": "MDM2", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3690", + "display": "FGFR3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1097", + "display": "BRAF", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3689", + "display": "FGFR2", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:18615", + "display": "BRAFP1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:34", + "display": "ABCA4", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + } + ] + }, + { + "id": "251c4538-efd4-41cb-ac11-7aa6004b4546", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "chromosome": "chr6", + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "startRange": { + "start": 10903, + "end": 10945 + }, + "endRange": { + "start": 11359, + "end": 11409 + }, + "totalCopyNumber": 7, + "relativeCopyNumber": 0.3329690143900391, + "cnA": 0.6937471513244393, + "cnB": 0.07580581478248649, + "reportedAffectedGenes": [ + { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1100", + "display": "BRCA1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3942", + "display": "MTOR", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:18615", + "display": "BRAFP1", + "system": "https://www.genenames.org/" + } + ], + "reportedFocality": "partial q-arm", + "type": { + "code": "high-level-gain", + "display": "High-level-gain", + "system": "dnpm-dip/mtb/ngs-report/cnv/type" + }, + "copyNumberNeutralLoH": [ + { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:25829", + "display": "ABRAXAS1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:3690", + "display": "FGFR3", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1097", + "display": "BRAF", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:9967", + "display": "RET", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:18615", + "display": "BRAFP1", + "system": "https://www.genenames.org/" + }, + { + "code": "HGNC:6407", + "display": "KRAS", + "system": "https://www.genenames.org/" + } + ] + } + ], + "dnaFusions": [ + { + "id": "1175b70b-b667-47b2-831d-c8537f035b47", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr19", + "gene": { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + }, + "position": 640 + }, + "fusionPartner3prime": { + "chromosome": "chr7", + "gene": { + "code": "HGNC:3689", + "display": "FGFR2", + "system": "https://www.genenames.org/" + }, + "position": 214 + }, + "reportedNumReads": 8 + }, + { + "id": "1554981f-5fb8-4af4-9469-9577039873a2", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "splicing-region", + "display": "splicing region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr17", + "gene": { + "code": "HGNC:1097", + "display": "BRAF", + "system": "https://www.genenames.org/" + }, + "position": 361 + }, + "fusionPartner3prime": { + "chromosome": "chr15", + "gene": { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + "position": 522 + }, + "reportedNumReads": 9 + }, + { + "id": "8acbfaea-f14a-4acc-bf2b-c704d5389528", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "coding-region", + "display": "Coding region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr20", + "gene": { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + "position": 545 + }, + "fusionPartner3prime": { + "chromosome": "chr22", + "gene": { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + }, + "position": 360 + }, + "reportedNumReads": 4 + }, + { + "id": "1b64154c-4998-4863-be54-015dbc4e15b1", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr1", + "gene": { + "code": "HGNC:6407", + "display": "KRAS", + "system": "https://www.genenames.org/" + }, + "position": 564 + }, + "fusionPartner3prime": { + "chromosome": "chr1", + "gene": { + "code": "HGNC:1777", + "display": "CDK6", + "system": "https://www.genenames.org/" + }, + "position": 985 + }, + "reportedNumReads": 4 + }, + { + "id": "a285967c-192c-4716-ae4c-db0fac6d8aa0", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "splicing-region", + "display": "splicing region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr21", + "gene": { + "code": "HGNC:21597", + "display": "ACAD10", + "system": "https://www.genenames.org/" + }, + "position": 155 + }, + "fusionPartner3prime": { + "chromosome": "chr11", + "gene": { + "code": "HGNC:21298", + "display": "AACS", + "system": "https://www.genenames.org/" + }, + "position": 115 + }, + "reportedNumReads": 3 + }, + { + "id": "1fb9a606-b876-4c54-b125-6b299b2fdc8d", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "intergenic", + "display": "Intergenic", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr16", + "gene": { + "code": "HGNC:25662", + "display": "AAGAB", + "system": "https://www.genenames.org/" + }, + "position": 723 + }, + "fusionPartner3prime": { + "chromosome": "chrX", + "gene": { + "code": "HGNC:886", + "display": "ATRX", + "system": "https://www.genenames.org/" + }, + "position": 964 + }, + "reportedNumReads": 8 + }, + { + "id": "31272996-075d-4b34-8357-2a81496f4081", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr4", + "gene": { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + "position": 219 + }, + "fusionPartner3prime": { + "chromosome": "chr18", + "gene": { + "code": "HGNC:33", + "display": "ABCA3", + "system": "https://www.genenames.org/" + }, + "position": 955 + }, + "reportedNumReads": 8 + }, + { + "id": "794aec2c-de1b-406c-94e0-e8248d5885d4", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "localization": [ + { + "code": "coding-region", + "display": "Coding region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "chromosome": "chr18", + "gene": { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + "position": 914 + }, + "fusionPartner3prime": { + "chromosome": "chr15", + "gene": { + "code": "HGNC:6407", + "display": "KRAS", + "system": "https://www.genenames.org/" + }, + "position": 299 + }, + "reportedNumReads": 8 + } + ], + "rnaFusions": [ + { + "id": "0c6512d1-d5c5-4600-8fe6-c0453d56c5fd", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "6dfcb9e2-e714-4fbc-ad4e-8fa2bea1a79f", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "transcriptId": { + "value": "ba78ec95-f31b-42b6-90d0-61161cad9b01", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "2", + "gene": { + "code": "HGNC:5173", + "display": "HRAS", + "system": "https://www.genenames.org/" + }, + "position": 307, + "strand": "-" + }, + "fusionPartner3prime": { + "transcriptId": { + "value": "8d01b4ea-bb9a-4bfd-9f94-e05e43956323", + "system": "https://www.ensembl.org" + }, + "exonId": "11", + "gene": { + "code": "HGNC:1100", + "display": "BRCA1", + "system": "https://www.genenames.org/" + }, + "position": 845, + "strand": "+" + }, + "effect": "Effect", + "reportedNumReads": 5 + }, + { + "id": "4093aaf4-b5a9-4a36-a027-bf3b4a313a6f", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "5e482aa3-e41f-4421-b21f-1b6ebd41c8db", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "localization": [ + { + "code": "regulatory-region", + "display": "Regulatory region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "transcriptId": { + "value": "699bbf71-c188-4727-8229-8fa933aac352", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "11", + "gene": { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + "position": 417, + "strand": "+" + }, + "fusionPartner3prime": { + "transcriptId": { + "value": "0963a4c5-b115-4e8e-bd2d-4a758dcee081", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "7", + "gene": { + "code": "HGNC:3236", + "display": "EGFR", + "system": "https://www.genenames.org/" + }, + "position": 230, + "strand": "+" + }, + "effect": "Effect", + "reportedNumReads": 5 + }, + { + "id": "c881e1ab-b776-40f5-b08c-69dc9aa0618d", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "7b636af7-c36e-463f-bb4d-35c02429cc0a", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "localization": [ + { + "code": "coding-region", + "display": "Coding region", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "transcriptId": { + "value": "83696ba9-2bf6-4525-8916-cfd7d6b57d8e", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "9", + "gene": { + "code": "HGNC:1097", + "display": "BRAF", + "system": "https://www.genenames.org/" + }, + "position": 549, + "strand": "+" + }, + "fusionPartner3prime": { + "transcriptId": { + "value": "3245f5a3-88a9-45b8-bed7-14cbb55208a3", + "system": "https://www.ensembl.org" + }, + "exonId": "10", + "gene": { + "code": "HGNC:391", + "display": "AKT1", + "system": "https://www.genenames.org/" + }, + "position": 472, + "strand": "-" + }, + "effect": "Effect", + "reportedNumReads": 9 + }, + { + "id": "08835215-46f5-4ee3-8c9e-7ac1eff090fd", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "externalIds": [ + { + "value": "344c53a9-8744-4d7f-873a-41ed56a6477f", + "system": "https://cancer.sanger.ac.uk/cosmic" + } + ], + "localization": [ + { + "code": "intergenic", + "display": "Intergenic", + "system": "dnpm-dip/variant/localization" + } + ], + "fusionPartner5prime": { + "transcriptId": { + "value": "7185fa47-ca77-4ffb-b7d4-96e0929c8beb", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "2", + "gene": { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + }, + "position": 942, + "strand": "-" + }, + "fusionPartner3prime": { + "transcriptId": { + "value": "c0bf67cd-f0ee-4ce6-b3d9-b9ced8174db4", + "system": "https://www.ncbi.nlm.nih.gov/refseq" + }, + "exonId": "9", + "gene": { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + }, + "position": 434, + "strand": "-" + }, + "effect": "Effect", + "reportedNumReads": 9 + } + ], + "rnaSeqs": [] + } + } + ], + "carePlans": [ + { + "id": "785d0496-4e74-492e-b8cf-73390b0f4954", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "issuedOn": "2025-07-09", + "geneticCounselingRecommendation": { + "id": "23452d54-dfa9-48f7-a191-7df1b94594c2", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "issuedOn": "2025-07-09", + "reason": { + "code": "secondary-tumor", + "display": "Zweittumor", + "system": "dnpm-dip/mtb/recommendation/genetic-counseling/reason" + } + }, + "medicationRecommendations": [ + { + "id": "55f1bead-15c6-4fd5-8aa8-ee4c9b2cb285", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "issuedOn": "2025-07-09", + "priority": { + "code": "3", + "display": "3", + "system": "dnpm-dip/recommendation/priority" + }, + "levelOfEvidence": { + "grading": { + "code": "m2C", + "display": "m2C", + "system": "dnpm-dip/mtb/level-of-evidence/grading" + }, + "addendums": [ + { + "code": "is", + "display": "is", + "system": "dnpm-dip/mtb/level-of-evidence/addendum" + } + ], + "publications": [ + { + "id": "1525598879", + "system": "https://pubmed.ncbi.nlm.nih.gov", + "type": "Publication" + } + ] + }, + "category": [ + { + "code": "IM", + "display": "Immun-/Antikörpertherapie", + "system": "dnpm-dip/mtb/recommendation/systemic-therapy/category" + } + ], + "medication": [ + { + "code": "L01FX03", + "display": "Catumaxomab", + "system": "http://fhir.de/CodeSystem/bfarm/atc", + "version": "2025" + } + ], + "useType": { + "code": "compassionate", + "display": "Compassionate Use", + "system": "dnpm-dip/mtb/recommendation/systemic-therapy/use-type" + }, + "supportingVariants": [ + { + "variant": { + "id": "4093aaf4-b5a9-4a36-a027-bf3b4a313a6f", + "type": "Variant" + }, + "gene": { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + } + } + ] + } + ], + "procedureRecommendations": [ + { + "id": "57720dff-86a6-4795-9ac2-0942e50b8191", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "issuedOn": "2025-07-09", + "priority": { + "code": "3", + "display": "3", + "system": "dnpm-dip/recommendation/priority" + }, + "levelOfEvidence": { + "grading": { + "code": "m2B", + "display": "m2B", + "system": "dnpm-dip/mtb/level-of-evidence/grading" + }, + "addendums": [ + { + "code": "R", + "display": "R", + "system": "dnpm-dip/mtb/level-of-evidence/addendum" + } + ], + "publications": [ + { + "id": "1386708679", + "system": "https://pubmed.ncbi.nlm.nih.gov", + "type": "Publication" + } + ] + }, + "code": { + "code": "OP", + "display": "Operation", + "system": "dnpm-dip/mtb/recommendation/procedure/category" + }, + "supportingVariants": [ + { + "variant": { + "id": "302808e8-25e5-44dd-bac1-1ec3bc901fca", + "type": "Variant" + }, + "gene": { + "code": "HGNC:11998", + "display": "TP53", + "system": "https://www.genenames.org/" + } + } + ] + } + ], + "studyEnrollmentRecommendations": [ + { + "id": "106ad35c-93c3-4c51-8da4-090489615969", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "issuedOn": "2025-07-09", + "levelOfEvidence": { + "grading": { + "code": "m2C", + "display": "m2C", + "system": "dnpm-dip/mtb/level-of-evidence/grading" + }, + "addendums": [ + { + "code": "is", + "display": "is", + "system": "dnpm-dip/mtb/level-of-evidence/addendum" + } + ], + "publications": [ + { + "id": "1525598879", + "system": "https://pubmed.ncbi.nlm.nih.gov", + "type": "Publication" + } + ] + }, + "priority": { + "code": "3", + "display": "3", + "system": "dnpm-dip/recommendation/priority" + }, + "study": [ + { + "id": "NCT69553088", + "system": "NCT", + "type": "Study" + } + ], + "supportingVariants": [ + { + "variant": { + "id": "4093aaf4-b5a9-4a36-a027-bf3b4a313a6f", + "type": "Variant" + }, + "gene": { + "code": "HGNC:1753", + "display": "CDH13", + "system": "https://www.genenames.org/" + } + } + ] + } + ], + "histologyReevaluationRequests": [ + { + "id": "b6fdf1d5-4434-47e7-97d8-3a085f772a07", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "specimen": { + "id": "c479b60d-c3e4-44d4-b0e5-c5891dd460ed", + "type": "TumorSpecimen" + }, + "issuedOn": "2025-07-09" + } + ], + "rebiopsyRequests": [ + { + "id": "5317db9f-af34-403f-8084-bed8d7822df7", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "tumorEntity": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "type": "MTBDiagnosis" + }, + "issuedOn": "2025-07-09" + } + ], + "notes": [ + "Protocol of the MTB conference..." + ] + } + ], + "followUps": [ + { + "date": "2009-08-12", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "lastContactDate": "2009-08-12" + } + ], + "claims": [ + { + "id": "d9d6e12f-46a2-4fe0-8aa8-1839a6bf22cb", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "recommendation": { + "id": "55f1bead-15c6-4fd5-8aa8-ee4c9b2cb285", + "type": "MTBMedicationRecommendation" + }, + "issuedOn": "2025-07-09", + "stage": { + "code": "follow-up-claim", + "display": "Folgeantrag", + "system": "dnpm-dip/mtb/claim/stage" + } + } + ], + "claimResponses": [ + { + "id": "159caaab-9792-4004-993e-9c9410915a8a", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "claim": { + "id": "d9d6e12f-46a2-4fe0-8aa8-1839a6bf22cb", + "type": "Claim" + }, + "issuedOn": "2025-07-09", + "status": { + "code": "unknown", + "display": "Unbekannt", + "system": "dnpm-dip/mtb/claim-response/status" + } + } + ], + "systemicTherapies": [ + { + "history": [ + { + "id": "f47600f1-9563-4964-b4db-1826faf01a52", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "reason": { + "id": "19de7fac-c8db-4936-b8fe-c47acda6599b", + "display": "Bösartige Neubildung: Sonstige und nicht näher bezeichnete Hirnnerven", + "type": "MTBDiagnosis" + }, + "intent": { + "code": "K", + "display": "Kurativ", + "system": "dnpm-dip/therapy/intent" + }, + "category": { + "code": "N", + "display": "Neoadjuvant", + "system": "dnpm-dip/therapy/category" + }, + "basedOn": { + "id": "55f1bead-15c6-4fd5-8aa8-ee4c9b2cb285", + "type": "MTBMedicationRecommendation" + }, + "recordedOn": "2025-07-09", + "status": { + "code": "on-going", + "display": "Laufend", + "system": "dnpm-dip/therapy/status" + }, + "recommendationFulfillmentStatus": { + "code": "partial", + "display": "Partiell", + "system": "dnpm-dip/therapy/recommendation-fulfillment-status" + }, + "dosage": { + "code": "over-50%", + "display": ">= 50 %", + "system": "dnpm-dip/therapy/dosage-density" + }, + "period": { + "start": "2009-04-29", + "end": "2009-10-21" + }, + "medication": [ + { + "code": "L01FX03", + "display": "Catumaxomab", + "system": "http://fhir.de/CodeSystem/bfarm/atc", + "version": "2025" + } + ], + "notes": [ + "Notes on the therapy..." + ] + } + ] + } + ], + "responses": [ + { + "id": "5da70b0a-e683-4de8-8671-b6508f237fc9", + "patient": { + "id": "fae56ea7-24a7-4556-82fb-2b5dde71bb4d", + "type": "Patient" + }, + "therapy": { + "id": "f47600f1-9563-4964-b4db-1826faf01a52", + "type": "MTBSystemicTherapy" + }, + "effectiveDate": "2009-08-12", + "method": { + "code": "RANO", + "display": "Nach RANO-Kriterien", + "system": "dnpm-dip/mtb/response/method" + }, + "value": { + "code": "SD", + "display": "Stable Disease", + "system": "RECIST" + } + } + ] +}